Provincial ADHD Program, BC Children's & Women's Health Centre
Vancouver, British Columbia, Canada
NCT Number: NCT00885807
The purpose of the study is to evaluate the psychometric validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record. It is hypothesized that the Weiss Functional Impairment Rating Scale has strong psychometric properties and good convergent validity with other measures of functioning and discriminant validity from symptoms and quality of life.
Looking for future studies?
Notify Me7 year and older
All sexes
Observational
Vancouver, British Columbia, Canada
The measures for this rating scale were developed at the request of the Canadian Attention Deficit Disorder Resource Alliance to provide clinician friendly tools free of charge as a way of improving screening for ADHD and comorbidity.
Patients are consented during clinic visits and agree to allow use of clinic data for the purpose of this research. They complete additional measure(s) for the purpose of the study. The data is then entered.
Internal consistency will be measured using Cronbach's alpha. Convergent, concurrent and discriminant validity will be measured using Pearson correlations. Domain reliability is determined with factor analysis. Up to 220 patients will be enrolled in the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
University of British Columbia
Other
Psychometric Validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record in Patients With Attention-Deficit Hyperactivity Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07633275
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Changsha, Hunan, China
View Trial DetailsNCT06185985
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
New York, United States
View Trial DetailsNCT01342445
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Bethlehem, Pennsylvania, United States
View Trial DetailsNCT05778526
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Hong Kong
View Trial Details